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Association Analysis of Interleukin-1β, Interleukin-6, and 
HMGB1 Variants with Postictal Serum Cytokine Levels 
in Children with Febrile Seizure and Generalized Epilepsy 
with Febrile Seizure Plus
Background and Purpose  Febrile seizure (FS) is a unique type of seizure that only occurs 
during childhood. Genelized epilepsy with febrile seizure plus (GEFS+) is a familial epilepsy 
syndrome associated with FS and afebrile seizure (AFS). Both seizure types are related to fever, 
but whether genetic susceptibility to inflammation is implicated in them is still unclear. To ana-
lyze the associations between postictal serum cytokine levels and genetic variants in the cytokine 
genes interleukin (IL)-1β, IL-6, and high mobility group box-1 (HMGB1) in FS and GEFS+.
Methods  Genotyping was performed in 208 subjects (57 patients with FS, 43 patients with 
GEFS+, and 108 controls) with the SNaPshot assay for IL-1β-31 (rs1143627), IL-1β-511 
(rs16944), IL-6-572 (rs1800796), and HMGB1 3814 (rs2249825). Serum IL-1β, IL-6, and 
HMGB1 levels were analyzed within 2 hours after seizure attacks using the ELISA in only 68 pa-
tients (38 FS, 10 GEFS+, and 20 controls). The allele distribution, genotype distribution, and 
correlations with serum cytokine levels were analyzed. 
Results  Near-complete linkage disequilibrium exists between IL-1β-31 and IL-1β-511 vari-
ants. CT genotypes of these variants were associated with significantly higher postictal serum 
IL-1β levels than were CC+TT genotypes in FS (both p<0.05). CT genotypes of IL-1β-31 and 
IL-1β-511 variants were more strongly associated with FS than were CC+TT genotypes (odds 
ratio=1.691 and 1.731, respectively). For GEFS+, serum IL-1β levels after AFS for CT geno-
types of IL-1β-31 and IL-1β-511 were also higher than for CC+TT genotypes. No significant 
associations were found for IL-6 and HMGB1.
Conclusions  Genetic variants located in IL-1β-31 and IL-1β-511 promotor regions are corre-
lated with higher postictal IL-1β levels in FS. These results suggest that IL-1 gene cluster variants 
in IL-1β-31 and IL-1β-511 are a host genetic factor for provoking FS in Korean children.
Key Words   interleukin-1β, interleukin-6, high mobility group box-1, febrile seizure, 
genelized epilepsy with febrile seizure plus, variant.
INTRODUCTION
Febrile seizure (FS) is defined as a seizure with fever in children younger than 6 years 
who have no history of epilepsy and without any obvious CNS infection, and it is the 
most common and unique form of seizure that only occurs during early childhood.1 Fe-
ver can be induced by various proinflammatory cytokines such as interleukin (IL)-1β, IL-
6, and tumor necrosis factor (TNF)-α during infections.2 Cytokine responses to infec-
tions can influence the body temperature, and the overproduction of proinflammatory 
cytokines may easily overwhelm the threshold for FS in children, which might be referred 
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to as a susceptibility to inflammation. 
Generalized epilepsy with febrile seizure plus (GEFS+) is 
a familial epilepsy syndrome associated with FS and epilep-
sy that is typically inherited with autosomal dominance and 
variable penetrance.3 A GEFS+ family is defined if it contains 
more than two patients with GEFS+ phenotypes.4 FS only is 
the most common phenotype, constituting 44% of GEFS+ 
families, while so-called FS+ is the second most common 
phenotype (27%,) which is defined as FS at older than 6 years 
or in a child with both FS and afebrile generalized tonic-
clonic seizure.5 The genes implicated in GEFS+ are the alpha-1 
neuronal voltage-gated sodium channel subunit Nav1.1 (SC-
N1A), the beta-1 subunit of the voltage-gated sodium channel 
(SCN1B), and the γ-aminobutyric acid (GABA)-A gamma-2 
receptor subunit (GABRG2).4 Although the most common 
phenotypes in GEFS+ are fever-related seizures, whether ge-
netic susceptibility to inflammation is implicated in GEFS+ 
is still unclear.
In our previous study we found elevations in both proin-
flammatory and anti-inflammatory cytokines such as IL-
1β, IL-6, TNF-α, high mobility group box-1 (HMGB1), and 
IL-10 in peripheral blood after FS in children with FS but 
also after an afebrile seizure (AFS) in children with epilepsy.6 
Moreover, IL-1β was significantly increased and was correlat-
ed with other proinflammatory cytokines including HMGB1 
after an FS attack compared to febrile children without a sei-
zure attack, implicating the cytokine network in the genera-
tion of FS.6 IL-1β has also been found to be increased in the 
CSF and epileptogenic brain lesions of children with epilepsy, 
suggesting that this cytokine is important in epilepsy initia-
tion and progression.7,8
A family history of FS is reportedly present in 17–30% of 
children with FS.2 The influences of cytokine gene variants 
on the susceptibility to FS have been controversial. The IL-
1β-511 promoter polymorphism was found to be associated 
with FS in a meta-analysis and lead to an increase in IL-1β 
production,9-11 but other studies have not found such associ-
ations.12,13 Moreover, there have been no human studies of 
the correlations of actual postictal serum cytokine levels with 
genotypes of cytokine genetic variants in children with FS.
In this study we analyzed the correlations of postictal se-
rum cytokine levels with the promotor variants of IL-1β, IL-
6, and HMGB1 in children with FS and GEFS+.
METHODS
Patient information
Children with FS or GEFS+ who visited the emergency room 
of Seoul Metropolitan Government Seoul National Universi-
ty Borame Medical Center were enrolled in this study (Table 
1). The inclusion criteria were children with FS aged between 
3 months and 5 years experiencing seizures associated with 
fever above 38°C and without CNS infection, neurologic def-
icits, or previous AFS.14 GEFS+ were diagnosed according 
to the criteria in the 2017 International Classification of Epi-
leptic Syndromes15 based on the clinical history and demo-
graphic findings of patients who developed both FS and AFS 
with a positive family history of FS or epilepsy. We excluded 
FS patients whose serum CRP levels were above 1.0 mg/dL in 
order to avoid the influence of severe infections accompany-
ing FS on cytokine profiles. 
Blood was obtained and DNA was extracted using Qiagen 
DNA purification kits (Germantown, MD, USA) and frozen 
for genotyping and sequencing. Serum was immediately 
separated only from patients who visited within 2 hours after 
an acute seizure attack, from FS patients after an FS attack, 
and from GEFS+ patients after an AFS attack, and then fro-
zen for subsequent cytokine assays. The difficulty of draw-
ing extra blood for cytokine measurements within 2 hours 
after seizures in addition to the routine blood work including 
blood cultures meant that the number of acute serum sam-
ples available for cytokine measurements was smaller than 
the total number of FS and GEFS+ patients. Postictal serum 
cytokine levels were available from 38 FS patients, 10 GEFS+ 
patients, and 20 febrile control children.
Clinical data about the familial FS history, the previous 
FS attack, and the semiology and time duration of FS were 
gathered from the parents of the patients. The controls were 
age matched and did not have previous FS or epilepsy. This 
study was approved by the Seoul Metropolitan Government 
Seoul National University Borame Medical Center Institu-
Table 1. Characteristics of the study subjects
FS GEFS+ Controls
Number of patients 57 43 106
Males/females 36 (63)/21 (37) 26 (60)/17 (40)




Simple 46 (81) 33 (75)
Complex  11 (19) 11 (25)
History of FS 3 (5) 4 (9)
Family history of epilepsy 0 (0) 12 (28)
Family history of FS 31 (72)
Age at afebrile seizure 
  onset, years
3.2±3.1
Antiepileptic medications, n 1.3
Data are n (%) or mean±SD values.
FS: febrile seizure, GEFS+: genetic epilepsy with febrile seizure plus, 
NA: not available.
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tional Review Board (approval numbers 20080918/06-2008- 
74/76), and informed consent was obtained from the parents 
of each child.
SNP selection and genotyping
Four variants located in the promotor regions of IL-1β-31 
(rs1143627), IL-1β-511 (rs16944), IL-1β-1003 (rs1143625), 
and IL-1β-1473 (rs1143623), four variants located in the pro-
motor regions of IL-6-174 (rs1800795), IL-6-572 (rs1800796), 
IL-6-597 (rs1800797), and IL-6-1426 (rs2069827), and the 
HMGB1 3814 (rs2249825) variant were initially selected 
from the HapMap human single nucleotide polymorphism 
(SNP) database (www.hapmap.org) and the dbSNP data-
base. However, IL-6-174 (rs1800795), IL-6-597 (rs1800797), 
and IL-6-1426 (rs2069827) were subsequently excluded due 
to having a minor allele frequency  of lower than 0.05 (Sup-
plementary Table 1 in the online-only Data Supplement). Har-
dy-Weinberg equilibrium exceed 0.05 in all patients. However, 
the Hardy-Weinberg equilibrium for controls was less than 
0.05 for IL-1β-1003 (rs1143625) and IL-1β-1473 (rs1143623) 
(Supplementary Table 1 in the online-only Data Supplement), 
and so those variants were also excluded when analyzing the 
data.
Pairwise linkage disequilibrium (LD) of SNP markers was 
estimated using Haploview (version 4.0; http://www.
broadinstitute.org/haploview). The default confidence inter-
val algorithm of the Haploview program identified one hap-
lotype block consisting of IL-1β-31 and IL-1β-511 from pa-
tient group data (Supplementary Fig. 1 in the online-only 
Data Supplement). Haplotypes were estimated using the 
HAPLOTYPE procedure in SAS/Genetics software (version 
13.1; SAS Co., Cary, NC, USA). 
Primer sequencing and genotyping
Probes and primers were designed with genomic sequence 
information. Genotyping was performed with the SNaPshot 
assay (Sequenom, San Diego, CA, USA). The person who 
analyzed the genotypes was blinded to the clinical data.
Cytokine measurement
IL-1β, IL-6, and HMGB1 serum levels were detected using 
ELISA according to the manufacturer’s instructions (Pa-
nomics, Redwood City, CA, USA; R&D Systems, Minneap-
olis, MN, USA; and Shino-Test Corporation, Tokyo, Japan16; 
respectively), with detection limits of 0.27, 0.23, and 0.2 ng/
mL, respectively.
Statistical analysis 
The Hardy-Weinberg equilibrium of each variants was eval-
uated using genotype data from all groups for goodness-of-
fit. The trend test, two-sided chi-square test with Yate’s cor-
rection, and Fisher’s exact test were used to analyze genotype 
differences between FS patients, GEFS+ patients, and con-
trols depending on the mode of inheritance,17 based on the 
minor allele of each variants. We used the logistic regression 
test to assess the associations of each variants with FS and 
GEFS+. The dependence of postictal serum cytokine levels 
on various cytokine genotypes was analyzed using the Krus-
kal-Wallis test or Mann-Whitney U test with multiple com-
parisons. IBM SPSS Statistics (version 20; IBM Corp., Ar-
monk, NY, USA), R (version 3.2.5; http://www.r-project.org), 
and GraphPad Prism (version 7.03; San Diego, CA, USA) were 
used to perform the tests. Mean values are quoted, and the 
criterion for significant differences was p<0.05 in all tests.
RESULTS
Characteristics of the subjects
Table 1 summarizes the clinical data of the included sub-
jects, who comprised 56 FS patients, 43 GEFS+ patients, and 
108 control children. Males were more prevalent than fe-
males among the FS and GEFS+ subjects (63% and 60%, re-
spectively). The semiology types of the FS attacks comprised 
81% simple and 19% complex. Three patients had histories 
of febrile status epilepticus, FS sustaining more than 30 min-
utes. 
All GEFS+ patients showed the evolution of epilepsy after 
an initial FS attack, and so were diagnosed by having both 
FS and AFS with a positive family history. Twelve patients 
(28%) had a family history of epilepsy and 72% of the pa-
tients had a family history of FS. The mean age at the first 
AFS was 3.2 years, and the GEFS+ patients had been treat-
ed with a mean of 1.3 antiepileptic medications. The mean 
age at testing due to an acute AFS attack was 8.6 years.
The postictal serum IL-1β, IL-6, and HMGB1 levels were 
significantly higher in FS patients than in controls (all p<0.05) 
(Fig. 1). The serum postictal cytokine levels in GEFS+ pa-
tients after AFS were higher than controls, but the difference 
between GEFS+ and controls showed no significance, statis-
tically (Fig. 1).
Allele comparisons 
The allele distributions in FS and GEFS+ patients are com-
pared to controls in Table 2. We also used the Korean Refer-
ence Genome Database for controls, which contains public 
data for 1,622 genome data of the Korean population (http://
coda.nih.go.kr/coda/KRGDB/index.jsp). The allele distribu-
tions in FS and GEFS+ patients did not differ from those in 
the controls. 
A  
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CT genotypes of IL-1β-31 and IL-1β-511 are
significantly correlated with higher postictal serum 
IL-1β levels in FS patients
CT genotypes of IL-1β-31 and IL-1β-511 showed significant 
correlations with higher postictal serum IL-1β levels com-
pared to CC+TT genotypes among FS patients (17.2 vs. 7.4 
pg/mL, both p<0.05) (Fig. 2A, B). Moreover, CT genotypes of 
the IL-1β-31 and IL-1β-511 variants showed stronger associa-
tions with FS than did CC+TT genotypes [odds ratio (OR)= 
1.691 and 1.731, respectively] (Table 3). 
IL-6-572 and HMGB1 3814 were not associated with 
genotypes or correlated with postictal serum levels in FS pa-
tients compared to controls (Fig. 3A, B). 
CT genotypes of IL-1β-31 and IL-1β-511 are 
correlated with higher postictal serum IL-1β levels 
in GEFS+ patients
IL-1β-31 and IL-1β-511 variants showed no statistically sig-
nificant correlation with postictal serum levels in GEFS+ pa-
tients after AFS attacks. Although, CT genotypes of both IL-
1β-31 and IL-1β-511 showed slightly higher postictal serum 
IL-1β levels compared to the CC+TT genotypes (4.1 vs. 1.2 
pg/mL, both p=0.476) (Fig. 2C, D). TT genotypes of IL-1β-31 
and CC genotypes of IL-1β-511 showed slightly stronger as-
sociations with GEFS+ (OR=1.886, OR=1.518; Table 3). 
IL-6-572 and HMGB1 3814 did not show significant as-
sociations between genotypes or correlations with postictal 
serum levels in GEFS+ patients compared to controls (Table 
3, Fig. 3C, D). 
Haplotype frequency analysis of the block with 
IL-1β-31 and IL-1β-511
The haplotype frequencies in the block of IL-1β-31 and IL-
1β-511 did not differ between FS and GEFS+ patients com-
pared to controls (Table 4). CC and TT haplotypes at IL-1β-31 
and IL-1β-511 were extremely rare (0–1.2%) and almost all 




































Fever only           FS               GEFS+ Fever only           FS               GEFS+ Fever only           FS               GEFS+
* *
*
A  B  C  
Fig. 1. Comparison of postictal serum cytokine levels in children with FS and GEFS+ compared to controls. Data are mean and standard-error val-
ues; *p<0.05 (A–C). Comparative analysis of postictal serum levels of IL-1β (A), IL-6 (B), and HMGB1 (C) between each group of FS and GEFS+ pa-
tients compared to controls. Postictal serum levels of IL-1β (A), IL-6 (B), and HMGB1 (C) were significantly increased in children with FS after an 
attack compared to controls. In children with GEFS+, postictal serum levels of IL-1β (A), IL-6 (B), and HMGB1 (C) after an afebrile seizure attack 
showed no statistically significant differences. FS: febrile seizure, GEFS+: genetic epilepsy with febrile seizure plus, HMGB1: high mobility group 
box-1, IL: interleukin.
Table 2. Allele frequencies in children with FS and GEFS+ compared to controls
SNP
Control (n=106) KRGDB (n=1,622) FS (n=57) GEFS+ (n=43)
n (%) (%) n (%) p n (%) p
IL-1β-31 (rs1143627) T 115 (54) (51)   60 (54) 0.908 40 (46.5) 0.225
C   97 (46) (49)   52 (46) 46 (53.5)
IL-1β-511 (rs16944) C 114 (54) (51)   60 (54) 0.903 42 (48.8) 0.394
T   96 (46) (49)   52 (46) 44 (51.2)
IL-6-572 (rs1800796) C 152 (72) (75)   85 (75) 0.672 66 (79.1) 0.273
G   58 (28) (25)   29 (25) 18 (20.9)
HMGB1 3814 (rs2249825) C 186 (89) (90) 104 (91) 0.337 80 (93.0) 0.201
G   26 (11) (10) 10 (9) 6 (7.0)
p values are from two-sided chi-square tests with Yate’s correction.
FS: febrile seizure, GEFS+: genetic epilepsy with febrile seizure plus, HMGB1: high mobility group box-1, IL: interleukin, KRGDB: Korean Reference Ge-
nome Database, SNP: single nucleotide polymorphism.
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Table 3. Genotype distributions in children with FS and GEFS+ compared to controls
SNP
Genotype frequency Genetic mode
Control (n=106) FS (n=57) GEFS+ (n=43) FS (n=57) GEFS+ (n=43)
n (%) n (%) p n (%) p OR p OR p
IL-1β-31
  (rs1143627)
TT 36 (34.0) 15 (26.3) 0.286   9 (20.9) 0.319 TT/TC/CC 1.025 0.912 1.320 0.256
CT 43 (40.6) 31 (54.4) 22 (51.2) TT/TC+CC 1.406 0.350 1.886 0.139
CC 27 (25.5) 11 (19.3) 12 (27.9) CC/TC+TT 0.715 0.405 1.170 0.700
TC/TT+CC 1.691 0.115 1.465 0.297
IL-1β-511
  (rs16944)
CC 36 (34.0) 16 (28.1) 0.256 11 (25.6) 0.579 CC/CT+TT 1.026 0.907 1.208 0.429
CT 43 (40.6) 30 (52.6) 20 (46.5) CC/CT+TT 1.426 0.331 1.518 0.303
TT 27 (25.7) 11 (19.3) 12 (27.9) TT/CT+CC 0.706 0.389 1.118 0.783
CT/CC+TT 1.731 0.100 1.304 0.467
IL-6-572
  (rs1800796)
CC 57 (53.8) 31 (54.4) 0.740 25 (58.1) 0.146 CC/CG/GG 0.895 0.674 0.707 0.268
CG 40 (37.7) 23 (40.4) 18 (41.9) CC/CG+GG 0.959 0.898 0.857 0.675
GG 9 (8.5) 3 (5.3) 0 (0.0) GG/CG+CC 0.593 0.447 0.000 0.990
CG/CC+GG 1.099 0.779 1.219 0.594
HMGB1 3814
  (rs2249825)
CC 82 (77.4) 48 (84.2) 0.568 38 (88.4) 0.269 CC/CG/GG 0.702 0.355 0.573 0.227
CG 22 (20.8)   8 (14.0) 4 (9.3) CC/CG+GG 0.641 0.302 0.462 0.145
GG 2 (1.9) 1 (1.8) 1 (2.3) GG/CG+CC 0.929 0.952 1.268 0.848
CG/CC+GG 0.623 0.294 0.402 0.115
































































D  TT     TC     CC             TT  TC+CC         CC  TC+TT          TC  TT+CC
Fig. 2. Correlation of postictal serum cytokine levels after an FS attack or after an AFS in GEFS+ depending on the genotypes of IL-1β variants (A–
D). Association analyses were performed between postictal serum levels of IL-1β and genotypes of IL-1β-31 and IL-1β-511 in children with FS (A 
and B) and GEFS+ (C and D). Postictal serum levels of IL-1β were significantly higher in CT genotypes of IL-1β-31 (A) and IL-1β-511 (B) than in 
CC+TT genotypes in children with FS after an FS attack (both p=0.032). In children with GEFS+, postictal serum levels of IL-1β did not show stati-
scally significant deferences between genotypes of IL-1β-31 (C) and IL-1β-511 (D) after an AFS attack. AFS: afebrile seizure, FS: febrile seizure, GEFS+: 
genetic epilepsy with febrile seizure plus.
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DISCUSSION
This is the first study showing proinflammatory cytokine 
IL-1β levels after an acute FS attack to be associated with 
genotypes of IL-1β-31 and IL-1β-511 promotor variants in 
children with FS. We found near-complete LD between the 
IL-1β-31 and IL-1β-511 variants, and the CT genotypes of 
both IL-1β-31 and IL-1β-511 showed significant correla-
tions with higher postictal serum IL-1β levels compared to 
the CC+TT genotypes in children with FS. For GEFS+, CT 
genotypes of both IL-1β-31 and IL-1β-511 did not show sig-
nificant association with postictal serum IL-1β after an AFS 
attack, probably being due to the small numbers of patients 
included. These data may support postictal serum IL-1β lev-
els varying depending on the genotypes of IL-1β promotor 
variants in individuals. Therefore, serum IL-1β levels can 
be a critical factor determining whether or not FS develops 
at the time of a febrile state, representing evidence of genet-
ic risk factors for fever-related seizures in children. However, 
we did not find a significant association between IL-6-572 
and HMGB1 3814, which are known to be important proin-
flammatory cytokines related to FS and epilepsy.
IL-1β reportedly provokes seizures and also can be pro-
duced after seizures in animal models of epilepsy.18 IL-1β pro-
vokes seizures via up-regulation of excitatory neurotransmis-























































C  D  GG     CG    CC             CC CG+GG         GG CG+CC         CG CC+GG GG     CG    CC             CC CG+GG         GG CG+CC         CG CC+GG
Fig. 3. Correlations of postictal serum cytokine levels after an FS attack or after an afebrile seizure in GEFS+ with the genotypes of IL-6 and HMGB1 
variants (A–D). Association analyses of postictal serum levels of IL-6 and HMGB1 were performed with genotypes of IL-6-572 and HMGB1 3814 in 
children with FS (A and B) and GEFS+ (C and D). Postictal serum IL-6 levels were not significantly associated with the genotypes of the IL-6-572 
variant both in FS (A) and GEFS+ (C). Postictal serum levels of HMGB1 were also not significantly associated with the genotypes of the HMGB1 3814 
variant both in FS (B) and GEFS+ (D). FS: febrile seizure, GEFS+: genetic epilepsy with febrile seizure plus.
Table 4. Haplotype frequency analysis of linkage disequilibrium in block 1 of IL-1β variants.
Variant number Haplotype
Control FS GEFS+
Frequency Frequency p Frequency p
IL-1β rs1143627, rs16944 CC 0.000 0.000 0.996 0.012 0.433
CT 0.458 0.464 0.512
TC 0.542 0.536 0.477
TT 0.000 0.000 0.000
FS: febrile seizure, GEFS+: genetic epilepsy with febrile seizure plus, IL: interleukin.
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neurotransmission.20 Moreover, the intraventricular injection 
of IL-1β can induce FS even at a lower body temperature in 
2-week-old mice during a febrile state.21 Seizure activity in 
itself triggers the production of cytokines in astrocytes and 
microglia, which are innate immune cells in the brain, even 
without peripheral immune cells or blood-borne mediators. 
IL-1β also enhances the main inflammatory responses and 
triggers the expression of other proinflammatory cytokine 
genes including IL-2, IL-6, IL-12, and TNF-α.22 Therefore, 
postictal IL-1β levels can be both a cause of seizures and a 
result of seizures. Although postictal serum IL-1β levels may 
reflect a result of seizures, higher sustained IL-1β levels also 
can trigger seizures. 
The production of cytokines seems to change according to 
variants of cytokine genes.23 The action of promoter variants 
on gene transcription may be complicated and involve inter-
actions with many variants sites. Therefore, genetic variants 
that up-regulate cytokine production can increase the degree 
of inflammatory responses to infection or other stimuli, 
which may subsequently predispose subjects to develop fever-
provoked seizures. In vitro stimulation of peripheral blood 
mononuclear cells with lipopolysaccharide, mimicking bac-
terial infection, reportedly demonstrates that IL-1β produc-
tion is higher in FS children than in controls.24
Several meta-analyses have investigated the associations 
of IL-1β promotor variants with the risk of FS. A recent me-
ta-analysis studies showed that IL-1β-511 genotypes are as-
sociated with FS in both Asians and Caucasians.11 However, 
the genotypes with the strongest associations differed be-
tween Asians and Caucasians, with CT+TT vs. CC for Cauca-
sian populations (OR=1.434) and TT vs. CC+CT for Asians 
(OR=1.393). These genetic differences may result from eth-
nic diversity or a lack of matching data on postictal IL-1β 
levels. There have been no previous reports on actual postictal 
IL-1β levels in FS with specific genotypes of the IL-1β-511 
variant. In the present study, CT vs. TT+CC at IL-1β-511 
showed significant correlations with higher postictal serum 
IL-1β levels, and the CT genotypes were associated with FS 
1.731-fold more than were the TT+CC genotypes. The postic-
tal serum IL-1β levels decreased in the following order of IL-
1β-511 genotypes: CT>TT>CC. This suggests that CT and 
TT genotypes represent more-susceptible genetic variants 
in FS than CC genotypes in Asian children, which is consis-
tent with the findings of a previous meta-analysis.11 The IL-
1β-31 variant involves a TATA-box polymorphism that 
markedly affects DNA–protein interactions in vitro.25 T al-
lele of IL-1β-511 reportedly up-regulates promotor activity, 
consequently increasing IL-1β production both in vitro and 
in vivo.9,26 The present study found near-complete LD be-
tween IL-1β-31 and IL-1β-511 variants, similar to a study of 
adult gastric cancer.25 If the genotype of IL-1β-31 is CT, the 
genotype of IL-1β-511 is also automatically determined as 
CT. The present study found that CT genotypes of both IL-
1β-31 and IL-1β-511 were significantly associated with high-
er postictal serum IL-1β levels in children with FS. This find-
ing may explain why the serum IL-1β level was identical in 
patients with CT genotypes of IL-1β-31 and IL-1β-511 in 
this study, because almost 99% of the patients carried CT 
or TC haplotype of IL-1β-31 and IL-1β-511. This situation 
made it impossible to evaluate the independent contribution 
of these variants to increased serum levels of IL-1β. Therefore, 
our results suggest that IL-1 gene cluster variants in IL-1β-31 
and IL-1β-511 are a host genetic factor for provoking FS in 
Korean children.
Heterozygote genetic variants in membrane receptors may 
express multiple actions that affect the phenotypes. There are 
studies showing associations of heterozygotes of IL-1β-3954 
(rs1143634) with posttraumatic epilepsy.27 In our results, 
heterozygotes of IL-1β promotor variants also showed sig-
nificant associations with fever-provoked seizures and higher 
postictal IL-1β levels in children with FS. Different isoforms 
of IL-1β of different genotypes may influence receptor bind-
ing, transcriptional activation, and inflammation signaling 
pathways.28 Diverse variants in a single gene may be related to 
multiple genes and factors in the pathway responsible for the 
development of seizures. Therefore, understanding the role of 
each genetic variant is needed to explain their interactions. 
GEFS+ is a familial epilepsy syndrome associated with FS 
and the subsequent development of epilepsy.3 However, the 
genetic mechanisms underlying the sensitivity to fever-relat-
ed seizures in GEFS+ are currently unknown. GEFS+ patients 
in the present study showed similar patterns of genotypes 
and postictal serum IL-1β levels found in FS. CT genotypes 
of both IL-1β-31 and IL-1β-511 showed relatively higher 
postictal serum IL-1β levels than CC and TT genotypes af-
ter an AFS attack, although statistically insignificant. The lack 
of statistical significance may have been due to the small num-
bers of patients enrolled or the presence of AFS rather than 
FS. However, even AFS in GEFS+ was correlated with higher 
postictal serum IL-1β in patients with CT genotypes com-
pared to TT+CC genotypes, suggesting that a genetic sus-
ceptibility to inflammation underlies seizure development. 
HMGB1 is involved in the development and recurrence of 
seizures, and HMGB1 antagonists suppress the precipitation 
and recurrence of seizures in animal models of epilepsy.29,30 
HMGB1 is also found at higher levels in epileptogenic brain 
lesions of epilepsy patients.29 Extracellular HMGB1 binds to 
IL-1β and lipopolysaccharide and enhances inflammatory ac-
tivities.31,32 Serum HMGB1 was found to be significantly in-
creased in children with FS and correlated with the serum IL-
562  J Clin Neurol 2019;15(4):555-563
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1β level.6 HMGB1 genes are highly conserved, with only 
seven variants being found and with an identical occurrence 
among various racial groups. The HMGB1 3814 polymor-
phism at intron 1 is known to affect the binding site of v-Myb, 
which is a powerful enhancer of HMGB1 expression.33 How-
ever, the HMGB1 3814 vatiant was not associated with ei-
ther FS or GEFS+ in the present study. 
IL-6 is a key proinflammatory cytokine involved in sys-
temic inflammatory processes and is related to many neuro-
inflammatory disorders. The IL-6-572 C allele could increase 
the transcriptional activity of IL-6 promoter, leading to the 
up-regulation of IL-6 in stress or infection.34 The IL-6-572 C 
allele reportedly acts as a biomarker of small-vessel diseases 
of the brain in elderly patients, suggesting the presence of 
chronic neuroinflammation.35 The IL-6-572 CC genotypes 
were associated with higher serum IL-6 levels compared to 
GG genotypes among cerebral palsy children, implicating an 
association with chronic prenatal neuroinflammation,34 but 
no differences were seen in Taiwanese FS children.13 The pres-
ent study also found no significant association of IL-6-572 
with either FS or GEFS+.
The main limitation of this study was the small number of 
patients for whom acute serum samples were available after 
an acute seizure attack, which was due to the difficulty of ob-
taining such samples from young children with FS or GEFS+. 
The number of acute postictal serum samples was small es-
pecially in GEFS+ compared to FS, which might have result-
ed in the absence of statistical significance in GEFS+. Parents 
of GEFS+ families have previous experience of AFS attacks, 
which makes them less likely to bring their children to the 
emergency department. Therefore, a multicenter large-scale 
study involving subjects of multiple races is needed to con-
firm the correlations between postictal serum cytokine levels 
and genetic variants in order to identify the genetic risk fac-
tors for FS and GEFS+. 
This is the first study demonstrating that proinflammatory 
cytokine IL-1β levels after an acute FS attack are associated 
with genotypes of IL-1β-31 and IL-1β-511 promotor vari-
ants in children with FS. Near-complete LD exists between 
the IL-1β-31 and IL-1β-511 variants, and CT genotypes of 
both IL-1β-31 and IL-1β-511 were significantly associated 
with higher postictal serum IL-1β levels compared to CC+TT 
genotypes in children with FS. These new data may indicate 
that promotor variants in IL-1β genes (and not IL-6 or HMGB1 
genes) are a potential genetic risk factor for fever-related sei-
zures in children. 
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